HRP20020303A8 - Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof - Google Patents
Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereofInfo
- Publication number
- HRP20020303A8 HRP20020303A8 HR20020303A HRP20020303A HRP20020303A8 HR P20020303 A8 HRP20020303 A8 HR P20020303A8 HR 20020303 A HR20020303 A HR 20020303A HR P20020303 A HRP20020303 A HR P20020303A HR P20020303 A8 HRP20020303 A8 HR P20020303A8
- Authority
- HR
- Croatia
- Prior art keywords
- intermediates
- preparation
- necrosis factor
- benzonaphthoazulenes
- inhibitors
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- UDEQOVGVLPGNGN-UHFFFAOYSA-N C12=CC=CC2=CC=CC2=C1C=CC1=CC=C(C=CC=C3)C3=C21 Chemical class C12=CC=CC2=CC=CC2=C1C=CC1=CC=C(C=CC=C3)C3=C21 UDEQOVGVLPGNGN-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title abstract 2
- 102000018594 Tumour necrosis factor Human genes 0.000 title 1
- 108050007852 Tumour necrosis factor Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000000589 Interleukin-1 Human genes 0.000 abstract 2
- 108010002352 Interleukin-1 Proteins 0.000 abstract 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR20020303A HRP20020303B8 (en) | 2002-04-10 | 2002-04-10 | Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
YU88104A YU88104A (sh) | 2002-04-10 | 2003-04-09 | 1-ili 3-tia benzonaftoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje |
US10/510,867 US20050137249A1 (en) | 2002-04-10 | 2003-04-09 | 1-or 3-thia-benznaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
SI200330152T SI1492795T1 (sl) | 2002-04-10 | 2003-04-09 | 1- ali 3-tia-benzonaftoazuleni kot inhibitorji proizvodnje tumorskega nekroznega faktorja in intermediati za njihovo pripravo |
RU2004132866/04A RU2318827C2 (ru) | 2002-04-10 | 2003-04-09 | ПРОИЗВОДНЫЕ БЕНЗОНАФТОАЗУЛЕНА, ПРИМЕНЕНИЕ ИХ В КАЧЕСТВЕ ПРОМЕЖУТОЧНЫХ ПРОДУКТОВ И ДЛЯ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ КОМПОЗИЦИЙ, ПРЕДНАЗНАЧЕННЫХ ДЛЯ ИНГИБИРОВАНИЯ ПРОДУЦИРОВАНИЯ ФНО-α |
MXPA04009872A MXPA04009872A (es) | 2002-04-10 | 2003-04-09 | 1-o 3-tia- benzonaftoazulenos como inhibidores de la produccion del factor de necrosis tumoral e intermediarios para la preparacion de los mismo. |
JP2003582158A JP2005526827A (ja) | 2002-04-10 | 2003-04-09 | 腫瘍壊死因子産生の阻害剤としてのベンゾナフトアズレン類及びその製造用中間体 |
NZ535622A NZ535622A (en) | 2002-04-10 | 2003-04-09 | 1-or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
IL16439503A IL164395A0 (en) | 2002-04-10 | 2003-04-09 | 1-Or-3-thia-benzonaphthoazulees as inhibitors of tumour necrosis factor production and intermediatesfor the preparation thereof |
EP03745847A EP1492795B1 (en) | 2002-04-10 | 2003-04-09 | 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
CNA038099578A CN1649876A (zh) | 2002-04-10 | 2003-04-09 | 作为肿瘤坏死因子产生抑制剂的1-或3-硫杂苯并萘并薁及用于其制备的中间产物 |
CA002481850A CA2481850A1 (en) | 2002-04-10 | 2003-04-09 | 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
DE60302344T DE60302344T2 (de) | 2002-04-10 | 2003-04-09 | 1- oder 3-thia-benzonaphthoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung |
PCT/HR2003/000014 WO2003084961A1 (en) | 2002-04-10 | 2003-04-09 | 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
AT03745847T ATE310005T1 (de) | 2002-04-10 | 2003-04-09 | 1- oder 3-thia-benzonaphthoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung |
PL03374005A PL374005A1 (en) | 2002-04-10 | 2003-04-09 | 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
KR10-2004-7016269A KR20050014806A (ko) | 2002-04-10 | 2003-04-09 | 종양 괴사 인자 생성 억제제로서의 1- 또는3-티아-벤조나프토아줄렌 및 그의 제조를 위한 중간체 |
ES03745847T ES2253694T3 (es) | 2002-04-10 | 2003-04-09 | 1- o 3-tia-benzonaftoazulenos como inhibidores de la produccion del factor de necrosis tumoral e intermedios para la preparacion de los mismos. |
AU2003259958A AU2003259958A1 (en) | 2002-04-10 | 2003-04-09 | 1- or 3-thia-benzonaphthoazulenes as inhibitors or tumour necrosis factor production and intermediates for the preparation thereof |
BR0309097-3A BR0309097A (pt) | 2002-04-10 | 2003-04-09 | Benzonaftoazulenos como inibidores de produção de fator de necrose de tumor e intermediários para a sua preparação |
UA20041008543A UA78297C2 (en) | 2002-04-10 | 2003-09-04 | 1- or 3-thiabenzonaphlhoazulene as inhibitors of tumour necrosis factor production and intermediates for synthesis thereof |
IS7472A IS7472A (is) | 2002-04-10 | 2004-09-27 | 1- eða 3-þía-bensónaftóasúlen sem hindrar fyrir æxlisdrepþáttar framleiðslu og milliefni til framleiðslu þeirra |
ZA200408059A ZA200408059B (en) | 2002-04-10 | 2004-10-06 | 1- or 3-Thia benzonaphthoazulenes as inhibitors oftumour necrosis factor production and intermediat es for the preparation thereof. |
US10/963,979 US7262309B2 (en) | 2002-04-10 | 2004-10-12 | 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
NO20044508A NO20044508L (no) | 2002-04-10 | 2004-10-21 | 1-eller 3-tia-henzonaftoazulener som inhibitorer av tumornektrosefaktorproduksjon og mellomprodukter for fremstilling derav |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR20020303A HRP20020303B8 (en) | 2002-04-10 | 2002-04-10 | Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
Publications (4)
Publication Number | Publication Date |
---|---|
HRP20020303A2 HRP20020303A2 (en) | 2003-10-31 |
HRP20020303B1 HRP20020303B1 (en) | 2007-05-31 |
HRP20020303A8 true HRP20020303A8 (en) | 2009-03-31 |
HRP20020303B8 HRP20020303B8 (en) | 2009-03-31 |
Family
ID=28686901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20020303A HRP20020303B8 (en) | 2002-04-10 | 2002-04-10 | Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
Country Status (24)
Country | Link |
---|---|
US (2) | US20050137249A1 (ru) |
EP (1) | EP1492795B1 (ru) |
JP (1) | JP2005526827A (ru) |
KR (1) | KR20050014806A (ru) |
CN (1) | CN1649876A (ru) |
AT (1) | ATE310005T1 (ru) |
AU (1) | AU2003259958A1 (ru) |
BR (1) | BR0309097A (ru) |
CA (1) | CA2481850A1 (ru) |
DE (1) | DE60302344T2 (ru) |
ES (1) | ES2253694T3 (ru) |
HR (1) | HRP20020303B8 (ru) |
IL (1) | IL164395A0 (ru) |
IS (1) | IS7472A (ru) |
MX (1) | MXPA04009872A (ru) |
NO (1) | NO20044508L (ru) |
NZ (1) | NZ535622A (ru) |
PL (1) | PL374005A1 (ru) |
RU (1) | RU2318827C2 (ru) |
SI (1) | SI1492795T1 (ru) |
UA (1) | UA78297C2 (ru) |
WO (1) | WO2003084961A1 (ru) |
YU (1) | YU88104A (ru) |
ZA (1) | ZA200408059B (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20020304B1 (en) * | 2002-04-10 | 2008-04-30 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof |
HRP20030160A2 (en) * | 2003-03-06 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | 1-thiadibenzoazulene derivatives and biological action thereof |
HRP20030954A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva D.D. | USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20030955A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20040104A2 (en) * | 2004-01-30 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
EP2460803B1 (en) * | 2009-07-28 | 2016-01-13 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for producing thiabenzoazulene propionic acid derivative |
EP2714064B1 (en) * | 2011-06-02 | 2019-05-15 | The Regents of The University of California | Blockade of inflammatory proteases with theta-defensins |
CN104163811A (zh) * | 2013-05-16 | 2014-11-26 | 重庆圣华曦药业股份有限公司 | 一种制备度洛西汀盐酸盐的新方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3711489A (en) * | 1971-03-31 | 1973-01-16 | Pfizer | Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles |
CA967573A (en) | 1972-12-22 | 1975-05-13 | Joseph G. Lombardino | Tetracyclic anti-inflammatory agents |
US4198421A (en) * | 1978-11-30 | 1980-04-15 | E. I. Du Pont De Nemours And Company | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles |
HRP20000310A2 (en) | 2000-05-17 | 2002-02-28 | Pliva Farmaceutska Ind Dioniko | New dibenzoazulene compounds as tumor necrosis factor inhibitors |
-
2002
- 2002-04-10 HR HR20020303A patent/HRP20020303B8/xx not_active IP Right Cessation
-
2003
- 2003-04-09 PL PL03374005A patent/PL374005A1/xx not_active Application Discontinuation
- 2003-04-09 CN CNA038099578A patent/CN1649876A/zh active Pending
- 2003-04-09 YU YU88104A patent/YU88104A/sh unknown
- 2003-04-09 EP EP03745847A patent/EP1492795B1/en not_active Expired - Lifetime
- 2003-04-09 DE DE60302344T patent/DE60302344T2/de not_active Expired - Fee Related
- 2003-04-09 BR BR0309097-3A patent/BR0309097A/pt not_active IP Right Cessation
- 2003-04-09 AT AT03745847T patent/ATE310005T1/de not_active IP Right Cessation
- 2003-04-09 ES ES03745847T patent/ES2253694T3/es not_active Expired - Lifetime
- 2003-04-09 KR KR10-2004-7016269A patent/KR20050014806A/ko not_active Application Discontinuation
- 2003-04-09 CA CA002481850A patent/CA2481850A1/en not_active Abandoned
- 2003-04-09 WO PCT/HR2003/000014 patent/WO2003084961A1/en active IP Right Grant
- 2003-04-09 NZ NZ535622A patent/NZ535622A/xx unknown
- 2003-04-09 IL IL16439503A patent/IL164395A0/xx unknown
- 2003-04-09 RU RU2004132866/04A patent/RU2318827C2/ru not_active IP Right Cessation
- 2003-04-09 US US10/510,867 patent/US20050137249A1/en not_active Abandoned
- 2003-04-09 AU AU2003259958A patent/AU2003259958A1/en not_active Abandoned
- 2003-04-09 SI SI200330152T patent/SI1492795T1/sl unknown
- 2003-04-09 JP JP2003582158A patent/JP2005526827A/ja active Pending
- 2003-04-09 MX MXPA04009872A patent/MXPA04009872A/es active IP Right Grant
- 2003-09-04 UA UA20041008543A patent/UA78297C2/uk unknown
-
2004
- 2004-09-27 IS IS7472A patent/IS7472A/is unknown
- 2004-10-06 ZA ZA200408059A patent/ZA200408059B/en unknown
- 2004-10-12 US US10/963,979 patent/US7262309B2/en not_active Expired - Fee Related
- 2004-10-21 NO NO20044508A patent/NO20044508L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA04009872A (es) | 2005-08-16 |
CN1649876A (zh) | 2005-08-03 |
CA2481850A1 (en) | 2003-10-16 |
DE60302344T2 (de) | 2006-07-27 |
US20050137249A1 (en) | 2005-06-23 |
RU2318827C2 (ru) | 2008-03-10 |
KR20050014806A (ko) | 2005-02-07 |
HRP20020303B1 (en) | 2007-05-31 |
BR0309097A (pt) | 2005-02-09 |
WO2003084961A1 (en) | 2003-10-16 |
JP2005526827A (ja) | 2005-09-08 |
HRP20020303A2 (en) | 2003-10-31 |
UA78297C2 (en) | 2007-03-15 |
PL374005A1 (en) | 2005-09-19 |
US7262309B2 (en) | 2007-08-28 |
YU88104A (sh) | 2006-08-17 |
HRP20020303B8 (en) | 2009-03-31 |
AU2003259958A1 (en) | 2003-10-20 |
SI1492795T1 (sl) | 2006-04-30 |
RU2004132866A (ru) | 2005-06-10 |
EP1492795A1 (en) | 2005-01-05 |
NZ535622A (en) | 2006-03-31 |
NO20044508L (no) | 2004-11-09 |
EP1492795B1 (en) | 2005-11-16 |
ZA200408059B (en) | 2005-10-06 |
ATE310005T1 (de) | 2005-12-15 |
IL164395A0 (en) | 2005-12-18 |
US20050130964A1 (en) | 2005-06-16 |
DE60302344D1 (de) | 2005-12-22 |
IS7472A (is) | 2004-09-27 |
ES2253694T3 (es) | 2006-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005105753A3 (en) | Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom | |
MXPA05010875A (es) | Derivados de piperazina como inhibidores de renina. | |
AU2003224923A1 (en) | Heterocyclic amide derivatives as cytokine inhibitors | |
IL164395A0 (en) | 1-Or-3-thia-benzonaphthoazulees as inhibitors of tumour necrosis factor production and intermediatesfor the preparation thereof | |
RS100104A (en) | 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof | |
CY1105036T1 (el) | 2-θεια-διβενζοαζουλενια ως αναστολεις της παραγωγης του παραγοντα νεκρωσης ογκων και ενδιαμεσα για την παρασκευη αυτων | |
MY136938A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
MY138550A (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
RS100004A (en) | 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof | |
WO2003097649A3 (en) | 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof | |
PL372456A1 (en) | 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof | |
RS100204A (en) | 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof | |
MY135359A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
MY136989A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
MY149837A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
PNAN | Change of the applicant name, address/residence |
Owner name: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O., |
|
PPPP | Transfer of rights |
Owner name: PLIVA-ISTRAZIVACKI INSTITUT D.O.O., HR |
|
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080402 Year of fee payment: 7 |
|
A8IS | Corrected front page of an hr-a document | ||
B8IS | Corrected front page of an hr-b document | ||
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20090411 |